Advertisement

Kidney Cancer pp 139-155 | Cite as

Renal Mass Biopsy

  • Kanishka SircarEmail author
  • Pheroze Tamboli
Chapter

Abstract

Evaluation of renal masses is critical for proper patient management. Clinical and radiological evaluation are paramount with the latter indicating whether a renal mass is solid or cystic and the complexity of a radiographically detected cyst using the Bosniak criteria. Historically, virtually all solid or complex cystic renal masses were surgically resected without biopsy confirmation as it did not alter management and was viewed as introducing unnecessary morbidity. Over the past two decades, clinical thinking has gradually changed to accept the safety and utility of renal mass biopsy for subsets of patients for whom histologic biopsy diagnosis is potentially useful. While the large majority of patients who undergo surgical resection of their renal masses are still not biopsied, many patients with smaller tumors who are candidates for ablation or surveillance or patients with advanced disease are increasingly biopsied in contemporary practice. Accordingly, we will discuss the clinical situations where renal mass biopsy may be indicated, its performance characteristics, as well as the general approach to pathologic evaluation and limitations of renal mass biopsy.

Keywords

Renal mass biopsy Biopsy of renal mass Bosniak criteria Nonrenal primary tumor Post biopsy hematoma Angiomyolipoma Metanephric adenoma Papillary adenoma 

References

  1. 1.
    Bosniak MA. The Bosniak renal cyst classification: 25 years later. Radiology. 2012;262:781–5.PubMedCrossRefGoogle Scholar
  2. 2.
    Kunkle DA, Egleston BL, Uzzo RG. Excise, ablate or observe: the small renal mass dilemma--a meta-analysis and review. J Urol. 2008;179:1227–33; discussion 33–4.PubMedCrossRefPubMedCentralGoogle Scholar
  3. 3.
    Leppert JT, Hanley J, Wagner TH, Chung BI, Srinivas S, Chertow GM, Brooks JD, Saigal CS, Urologic Diseases in America P. Utilization of renal mass biopsy in patients with renal cell carcinoma. Urology. 2014;83:774–9.PubMedPubMedCentralCrossRefGoogle Scholar
  4. 4.
    Appelbaum AH, Kamba TT, Cohen AS, Qaisi WG, Amirkhan RH. Effectiveness and safety of image-directed biopsies: coaxial technique versus conventional fine-needle aspiration. South Med J. 2002;95:212–7.PubMedCrossRefGoogle Scholar
  5. 5.
    Breda A, Treat EG, Haft-Candell L, Leppert JT, Harper JD, Said J, Raman S, Smith RB, Belldegrun AS, Schulam PG. Comparison of accuracy of 14-, 18- and 20-G needles in ex-vivo renal mass biopsy: a prospective, blinded study. BJU Int. 2010;105:940–5.PubMedCrossRefGoogle Scholar
  6. 6.
    Rybicki FJ, Shu KM, Cibas ES, Fielding JR, van Sonnenberg E, Silverman SG. Percutaneous biopsy of renal masses: sensitivity and negative predictive value stratified by clinical setting and size of masses. AJR Am J Roentgenol. 2003;180:1281–7.PubMedCrossRefGoogle Scholar
  7. 7.
    Hobbs DJ, Zhou M, Campbell SC, Aydin H, Weight CJ, Lane BR. The impact of location and number of cores on the diagnostic accuracy of renal mass biopsy: an ex vivo study. World J Urol. 2013;31:1159–64.PubMedCrossRefGoogle Scholar
  8. 8.
    Ginzburg S, Tomaszewski JJ, Kutikov A. Focal ablation therapy for renal cancer in the era of active surveillance and minimally invasive partial nephrectomy. Nat Rev Urol. 2017;14:669–82.PubMedCrossRefGoogle Scholar
  9. 9.
    Woldrich JM, Palazzi K, Stroup SP, Sur RL, Parsons JK, Chang D, Derweesh IH. Trends in the surgical management of localized renal masses: thermal ablation, partial and radical nephrectomy in the USA, 1998-2008. BJU Int. 2013;111:1261–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Ljungberg B, Bensalah K, Canfield S, Dabestani S, Hofmann F, Hora M, Kuczyk MA, Lam T, Marconi L, Merseburger AS, Mulders P, Powles T, Staehler M, Volpe A, Bex A. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol. 2015;67:913–24.PubMedCrossRefGoogle Scholar
  11. 11.
    Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: part 1, indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol. 2005;185:64–71.PubMedCrossRefGoogle Scholar
  12. 12.
    Breen DJ, Rutherford EE, Stedman B, Roy-Choudhury SH, Cast JE, Hayes MC, Smart CJ. Management of renal tumors by image-guided radiofrequency ablation: experience in 105 tumors. Cardiovasc Intervent Radiol. 2007;30:936–42.PubMedPubMedCentralCrossRefGoogle Scholar
  13. 13.
    Caputo PA, Zargar H, Ramirez D, Andrade HS, Akca O, Gao T, Kaouk JH. Cryoablation versus partial nephrectomy for clinical T1b renal tumors: a matched group comparative analysis. Eur Urol. 2017;71:111–7.PubMedCrossRefGoogle Scholar
  14. 14.
    Lay AH, Faddegon S, Olweny EO, Morgan M, Lorber G, Trimmer C, Leveillee R, Cadeddu JA, Gahan JC. Oncologic efficacy of radio frequency ablation for small renal masses: clear cell vs papillary subtype. J Urol. 2015;194:653–7.PubMedCrossRefGoogle Scholar
  15. 15.
    Halverson SJ, Kunju LP, Bhalla R, Gadzinski AJ, Alderman M, Miller DC, Montgomery JS, Weizer AZ, Wu A, Hafez KS, Wolf JS Jr. Accuracy of determining small renal mass management with risk stratified biopsies: confirmation by final pathology. J Urol. 2013;189:441–6.PubMedCrossRefGoogle Scholar
  16. 16.
    Karam JA, Ahrar K, Vikram R, Romero CA, Jonasch E, Tannir NM, Rao P, Wood CG, Matin SF. Radiofrequency ablation of renal tumours with clinical, radiographical and pathological results. BJU Int. 2013;111:997–1005.PubMedPubMedCentralCrossRefGoogle Scholar
  17. 17.
    Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst. 2006;98:1331–4.PubMedCrossRefGoogle Scholar
  18. 18.
    Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol. 2003;170:2217–20.CrossRefGoogle Scholar
  19. 19.
    Lane BR, Babineau D, Kattan MW, Novick AC, Gill IS, Zhou M, Weight CJ, Campbell SC. A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy. J Urol. 2007;178:429–34.CrossRefGoogle Scholar
  20. 20.
    Gill IS, Aron M, Gervais DA, Jewett MA. Clinical practice. Small renal mass. N Engl J Med. 2010;362:624–34.PubMedCrossRefGoogle Scholar
  21. 21.
    Remzi M, Ozsoy M, Klingler HC, Susani M, Waldert M, Seitz C, Schmidbauer J, Marberger M. Are small renal tumors harmless? Analysis of histopathological features according to tumors 4 cm or less in diameter. J Urol. 2006;176:896–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Pahernik S, Ziegler S, Roos F, Melchior SW, Thuroff JW. Small renal tumors: correlation of clinical and pathological features with tumor size. J Urol. 2007;178:414–7; discussion 6–7.PubMedCrossRefGoogle Scholar
  23. 23.
    Nguyen MM, Gill IS. Effect of renal cancer size on the prevalence of metastasis at diagnosis and mortality. J Urol. 2009;181:1020–7; discussion 7.PubMedCrossRefGoogle Scholar
  24. 24.
    Klatte T, Patard JJ, de Martino M, Bensalah K, Verhoest G, de la Taille A, Abbou CC, Allhoff EP, Carrieri G, Riggs SB, Kabbinavar FF, Belldegrun AS, Pantuck AJ. Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas. J Urol. 2008;179:1719–26.PubMedCrossRefGoogle Scholar
  25. 25.
    Silverman SG, Gan YU, Mortele KJ, Tuncali K, Cibas ES. Renal masses in the adult patient: the role of percutaneous biopsy. Radiology. 2006;240:6–22.PubMedCrossRefGoogle Scholar
  26. 26.
    Caoili EM, Davenport MS. Role of percutaneous needle biopsy for renal masses. Semin Intervent Radiol. 2014;31:20–6.PubMedPubMedCentralCrossRefGoogle Scholar
  27. 27.
    Patel HD, Johnson MH, Pierorazio PM, Sozio SM, Sharma R, Iyoha E, Bass EB, Allaf ME. Diagnostic accuracy and risks of biopsy in the diagnosis of a renal mass suspicious for localized renal cell carcinoma: systematic review of the literature. J Urol. 2016;195:1340–7.PubMedPubMedCentralCrossRefGoogle Scholar
  28. 28.
    Leveridge MJ, Finelli A, Kachura JR, Evans A, Chung H, Shiff DA, Fernandes K, Jewett MA. Outcomes of small renal mass needle core biopsy, nondiagnostic percutaneous biopsy, and the role of repeat biopsy. Eur Urol. 2011;60:578–84.PubMedCrossRefGoogle Scholar
  29. 29.
    Mullins JK, Rodriguez R. Renal cell carcinoma seeding of a percutaneous biopsy tract. Can Urol Assoc J. 2013;7:E176–9.PubMedPubMedCentralCrossRefGoogle Scholar
  30. 30.
    Prince J, Bultman E, Hinshaw L, Drewry A, Blute M, Best S, Lee FT Jr, Ziemlewicz T, Lubner M, Shi F, Nakada SY, Abel EJ. Patient and tumor characteristics can predict nondiagnostic renal mass biopsy findings. J Urol. 2015;193:1899–904.PubMedCrossRefGoogle Scholar
  31. 31.
    Park SY, Park BK, Kim CK, Kwon GY. Ultrasound-guided core biopsy of small renal masses: diagnostic rate and limitations. J Vasc Interv Radiol. 2013;24:90–6.PubMedCrossRefPubMedCentralGoogle Scholar
  32. 32.
    Shannon BA, Cohen RJ, de Bruto H, Davies RJ. The value of preoperative needle core biopsy for diagnosing benign lesions among small, incidentally detected renal masses. J Urol. 2008;180:1257–61; discussion 61.PubMedCrossRefGoogle Scholar
  33. 33.
    Salem S, Ponsky LE, Abouassaly R, Cherullo EE, Isariyawongse JP, Maclennan GT, Nakamoto D, Haaga JR. Image-guided biopsy of small renal masses in the era of ablative therapies. Int J Urol. 2013;20:580–4.PubMedCrossRefPubMedCentralGoogle Scholar
  34. 34.
    Richard PO, Jewett MA, Bhatt JR, Kachura JR, Evans AJ, Zlotta AR, Hermanns T, Juvet T, Finelli A. Renal tumor biopsy for small renal masses: a single-center 13-year experience. Eur Urol. 2015;68:1007–13.PubMedCrossRefGoogle Scholar
  35. 35.
    Gellert LL, Mehra R, Chen YB, Gopalan A, Fine SW, Al-Ahmadie H, Reuter VE, Tickoo SK. The diagnostic accuracy of percutaneous renal needle core biopsy and its potential impact on the clinical management of renal cortical neoplasms. Arch Pathol Lab Med. 2014;138:1673–9.PubMedCrossRefPubMedCentralGoogle Scholar
  36. 36.
    Somani BK, Nabi G, Thorpe P, N’Dow J, Swami S, McClinton S, Aberdeen A, Clinical Urological Surgeons G. Image-guided biopsy-diagnosed renal cell carcinoma: critical appraisal of technique and long-term follow-up. Eur Urol. 2007;51:1289–95; discussion 96–7.PubMedCrossRefGoogle Scholar
  37. 37.
    Lebret T, Poulain JE, Molinie V, Herve JM, Denoux Y, Guth A, Scherrer A, Botto H. Percutaneous core biopsy for renal masses: indications, accuracy and results. J Urol. 2007;178:1184–8; discussion 8.PubMedCrossRefPubMedCentralGoogle Scholar
  38. 38.
    Wang R, Wolf JS Jr, Wood DP Jr, Higgins EJ, Hafez KS. Accuracy of percutaneous core biopsy in management of small renal masses. Urology. 2009;73:586–90; discussion 90–1.PubMedCrossRefGoogle Scholar
  39. 39.
    Lhermitte B, de Leval L. Interpretation of needle biopsies of the kidney for investigation of renal masses. Virchows Arch. 2012;461:13–26.PubMedCrossRefPubMedCentralGoogle Scholar
  40. 40.
    Maturen KE, Nghiem HV, Caoili EM, Higgins EG, Wolf JS Jr, Wood DP Jr. Renal mass core biopsy: accuracy and impact on clinical management. AJR Am J Roentgenol. 2007;188:563–70.PubMedCrossRefGoogle Scholar
  41. 41.
    Shah RB, Bakshi N, Hafez KS, Wood DP Jr, Kunju LP. Image-guided biopsy in the evaluation of renal mass lesions in contemporary urological practice: indications, adequacy, clinical impact, and limitations of the pathological diagnosis. Hum Pathol. 2005;36:1309–15.PubMedGoogle Scholar
  42. 42.
    Menogue SR, O’Brien BA, Brown AL, Cohen RJ. Percutaneous core biopsy of small renal mass lesions: a diagnostic tool to better stratify patients for surgical intervention. BJU Int. 2013;111:E146–51.PubMedCrossRefGoogle Scholar
  43. 43.
    Millet I, Curros F, Serre I, Taourel P, Thuret R. Can renal biopsy accurately predict histological subtype and Fuhrman grade of renal cell carcinoma? J Urol. 2012;188:1690–4.PubMedCrossRefGoogle Scholar
  44. 44.
    Volpe A, Mattar K, Finelli A, Kachura JR, Evans AJ, Geddie WR, Jewett MA. Contemporary results of percutaneous biopsy of 100 small renal masses: a single center experience. J Urol. 2008;180:2333–7.PubMedCrossRefGoogle Scholar
  45. 45.
    Schmidbauer J, Remzi M, Memarsadeghi M, Haitel A, Klingler HC, Katzenbeisser D, Wiener H, Marberger M. Diagnostic accuracy of computed tomography-guided percutaneous biopsy of renal masses. Eur Urol. 2008;53:1003–11.PubMedCrossRefGoogle Scholar
  46. 46.
    Al-Ahmadie HA, Alden D, Fine SW, Gopalan A, Touijer KA, Russo P, Reuter VE, Tickoo SK. Role of immunohistochemistry in the evaluation of needle core biopsies in adult renal cortical tumors: an ex vivo study. Am J Surg Pathol. 2011;35:949–61.PubMedCrossRefGoogle Scholar
  47. 47.
    Sofikerim M, Tatlisen A, Canoz O, Tokat F, Demirtas A, Mavili E. What is the role of percutaneous needle core biopsy in diagnosis of renal masses? Urology. 2010;76:614–8.PubMedCrossRefGoogle Scholar
  48. 48.
    Abel EJ, Culp SH, Matin SF, Tamboli P, Wallace MJ, Jonasch E, Tannir NM, Wood CG. Percutaneous biopsy of primary tumor in metastatic renal cell carcinoma to predict high risk pathological features: comparison with nephrectomy assessment. J Urol. 2010;184:1877–81.PubMedPubMedCentralCrossRefGoogle Scholar
  49. 49.
    Abel EJ, Culp SH, Meissner M, Matin SF, Tamboli P, Wood CG. Identifying the risk of disease progression after surgery for localized renal cell carcinoma. BJU Int. 2010;106:1277–83.PubMedCrossRefGoogle Scholar
  50. 50.
    Reichelt O, Gajda M, Chyhrai A, Wunderlich H, Junker K, Schubert J. Ultrasound-guided biopsy of homogenous solid renal masses. Eur Urol. 2007;52:1421–6.PubMedCrossRefGoogle Scholar
  51. 51.
    Patel HD, Druskin SC, Rowe SP, Pierorazio PM, Gorin MA, Allaf ME. Surgical histopathology for suspected oncocytoma on renal mass biopsy: a systematic review and meta-analysis. BJU Int. 2017;119:661–6.CrossRefGoogle Scholar
  52. 52.
    Alderman MA, Daignault S, Wolf JS Jr, Palapattu GS, Weizer AZ, Hafez KS, Kunju LP, Wu AJ. Categorizing renal oncocytic neoplasms on core needle biopsy: a morphologic and immunophenotypic study of 144 cases with clinical follow-up. Hum Pathol. 2016;55:1–10.PubMedCrossRefGoogle Scholar
  53. 53.
    Amin MB, Paner GP, Alvarado-Cabrero I, Young AN, Stricker HJ, Lyles RH, Moch H. Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases. Am J Surg Pathol. 2008;32:1822–34.PubMedCrossRefGoogle Scholar
  54. 54.
    Petersson F, Gatalica Z, Grossmann P, Perez Montiel MD, Alvarado Cabrero I, Bulimbasic S, Swatek A, Straka L, Tichy T, Hora M, Kuroda N, Legendre B, Michal M, Hes O. Sporadic hybrid oncocytic/chromophobe tumor of the kidney: a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases. Virchows Arch. 2010;456:355–65.PubMedCrossRefPubMedCentralGoogle Scholar
  55. 55.
    Pote N, Vieillefond A, Couturier J, Arrufat S, Metzger I, Delongchamps NB, Camparo P, Mege-Lechevallier F, Molinie V, Sibony M. Hybrid oncocytic/chromophobe renal cell tumours do not display genomic features of chromophobe renal cell carcinomas. Virchows Arch. 2013;462:633–8.PubMedCrossRefGoogle Scholar
  56. 56.
    Aslam MI, Spencer L, Garcea G, Pollard C, Metcalfe MS, Harrison RF, Dennison AR. A case of liver metastasis from an oncocytoma with a focal area of chromophobe renal cell carcinoma: a wolf in sheep’s clothing. Int J Surg Pathol. 2009;17:158–62.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Division of Pathology and Laboratory Medicine, Departments of Pathology and Translational Molecular PathologyThe University of Texas MD Anderson Cancer CenterHoustonUSA
  2. 2.Division of Pathology and Laboratory Medicine, Department of PathologyThe University of Texas MD Anderson Cancer CenterHoustonUSA

Personalised recommendations